Protective human antibodies against a conserved epitope in pre- and postfusion influenza hemagglutinin
Proceedings of the National Academy of Sciences · 02.01.2024 · 121 (1)
DOI: 10.1073/pnas.2316964120 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 26.12.2023. Verfasst von Joel Finney und 16 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Molecular Medicine, Children's Hospital, Harvard Medical School, Boston, MA 02115. Hauptthemen laut MEDLINE: Influenza, Human, Influenza Vaccines, Influenza A virus, Orthomyxoviridae Infections. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIGMS NIH HHS, HHS | NIH | National Institute of Allergy and Infectious Diseases.
Abstract (Originalsprache)
Phylogenetically and antigenically distinct influenza A and B viruses (IAV and IBV) circulate in human populations, causing widespread morbidity. Antibodies (Abs) that bind epitopes conserved in both IAV and IBV hemagglutinins (HAs) could protect against disease by diverse virus subtypes. Only one reported HA Ab, isolated from a combinatorial display library, protects against both IAV and IBV. Thus, there has been so far no information on the likelihood of finding naturally occurring human Abs that bind HAs of diverse IAV subtypes and IBV lineages. We have now recovered from several unrelated human donors five clonal Abs that bind a conserved epitope preferentially exposed in the postfusion conformation of IAV and IVB HA2. These Abs lack neutralizing activity in vitro but in mice provide strong, IgG subtype–dependent protection against lethal IAV and IBV infections. Strategies to elicit similar Abs routinely might contribute to more effective influenza vaccines.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Molecular Medicine, Children's Hospital, Harvard Medical School, Boston, MA 02115.
- Department of Integrative Immunobiology, Duke University, Durham, NC 27710.
- Department of Surgery, Duke University, Durham, NC 27710.
- The Harvard Cryo-Electron Microscopy (Cryo-EM) Center for Structural Biology, Harvard Medical School, Boston, MA 02115.
- Department of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Boston, MA 02115.
- Center for Vaccine Research, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261.
ORCID-Profile: Kevin R McCarthy, Stephen C Harrison, Garnett Kelsoe
Förderung
- NIAID NIH HHS
- NIGMS NIH HHS
- HHS | NIH | National Institute of Allergy and Infectious Diseases
- Howard Hughes Medical Institute
Zitieren
APA
Finney, J., Moseman, A. P., Kong, S., Watanabe, A., Song, S., Walsh, R. M., Kuraoka, M., Kotaki, R., Moseman, E. A., McCarthy, K. R., Liao, D., Liang, X., Nie, X., Lavidor, O., Abbott, R., Harrison, S. C., & Kelsoe, G. (2024). Protective human antibodies against a conserved epitope in pre- and postfusion influenza hemagglutinin. Proceedings of the National Academy of Sciences, 121(1). https://doi.org/10.1073/pnas.2316964120
Vancouver
Finney J, Moseman AP, Kong S, Watanabe A, Song S, Walsh RM, et al. Protective human antibodies against a conserved epitope in pre- and postfusion influenza hemagglutinin. Proceedings of the National Academy of Sciences. 2024;121(1). doi:10.1073/pnas.2316964120
BibTeX
@article{Finney2024,
author = {Finney, Joel and Moseman, Annie Park and Kong, Susan and Watanabe, Akiko and Song, Shengli and Walsh, Richard M and Kuraoka, Masayuki and Kotaki, Ryutaro and Moseman, E Ashley and McCarthy, Kevin R and Liao, Dongmei and Liang, Xiaoe and Nie, Xiaoyan and Lavidor, Olivia and Abbott, Richard and Harrison, Stephen C and Kelsoe, Garnett},
title = {Protective human antibodies against a conserved epitope in pre- and postfusion influenza hemagglutinin},
journal = {Proceedings of the National Academy of Sciences},
year = {2024},
volume = {121},
number = {1},
doi = {10.1073/pnas.2316964120}
}
EUVIMED